Skip to content

Author

Shang-Chin Huang

We have 4 of 64 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Oct 2026

Evaluating the potential of treatment options for chronic hepatitis B.

The spectrum of established and emerging treatment options for CHB is evaluated, organized around quantitative HBsAg (qHBsAg) as the axis for selecting and sequencing therapy, organized around quantitative HBsAg (qHBsAg) as the axis for selecting and sequencing therapy.

Shang-Chin Huang, J. Kao · 1 citation
Sep 2026

The Impact of HCC Surveillance on Tumor Features and Receipt of Curative Therapy: A Focus on Chronic Hepatitis B and MASLD.

BACKGROUND As hepatocellular carcinoma (HCC) etiologies shift from viral to non-viral, many at-risk patients lack surveillance in real-world practice. This study characterizes the clinical features and receipt of curative therapy in HCC patients with and without surveillance. METHODS A retrospective cohort study was...

Shao-Li Huang, Hsi-An Chen, Chun-Hsun Liao et al. · 1 citation
Sep 2026

Clinical utility of combined amyloid biomarkers in early cognitive impairment.

While PET refines etiological diagnosis, p-tau217 serves as a robust predictor of amyloid status and cognitive trajectory, and integrating these biomarkers improves risk stratification and may facilitate patient selection for disease-modifying therapies.

Pu-Tien Chiang, Shao-Ying Cheng, Sung-Ju Hsueh et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.